GE HealthCare (NASDAQ: GEHC) reported Q2 EPS of $0.92, $0.06 better than the analyst estimate of $0.86. Revenue for the quarter came in at $4.82 billion versus the consensus estimate of $4.77 billion.

GUIDANCE:

GE HealthCare sees FY2023 EPS of $3.70-$3.85, versus the consensus of $3.74.

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.